Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3349143rdf:typepubmed:Citationlld:pubmed
pubmed-article:3349143lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:3349143lifeskim:mentionsumls-concept:C0011853lld:lifeskim
pubmed-article:3349143lifeskim:mentionsumls-concept:C0596236lld:lifeskim
pubmed-article:3349143lifeskim:mentionsumls-concept:C0805426lld:lifeskim
pubmed-article:3349143pubmed:issue2lld:pubmed
pubmed-article:3349143pubmed:dateCreated1988-5-6lld:pubmed
pubmed-article:3349143pubmed:abstractTextIn experimental alloxan diabetes marked hypocalcemia and hyperglycemia are observed in the blood of rats during the acute period of the disease (from 1.5 to 2 months). After 2.5-3.5 months of diabetes calcium level reaches the upper normal limit. Simultaneously, antibodies to calcitonin appear. It is quite likely that excessive calcitonin secretion, leading to hypocalcemia, decreased insulin secretion and hyperglycemia take place in the acute stage of diabetes. When diabetes persists the antibodies to calcitonin which reveal a homeostatic reaction blocking the excess of calcitonin appear. This normalizes the level of calcium in the blood and prevents the further increase in the blood sugar level.lld:pubmed
pubmed-article:3349143pubmed:languageruslld:pubmed
pubmed-article:3349143pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3349143pubmed:citationSubsetIMlld:pubmed
pubmed-article:3349143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3349143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3349143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3349143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3349143pubmed:statusMEDLINElld:pubmed
pubmed-article:3349143pubmed:monthFeblld:pubmed
pubmed-article:3349143pubmed:issn0365-9615lld:pubmed
pubmed-article:3349143pubmed:authorpubmed-author:TsvetkovV SVSlld:pubmed
pubmed-article:3349143pubmed:authorpubmed-author:BondarenkoM...lld:pubmed
pubmed-article:3349143pubmed:authorpubmed-author:KulikovaL ILIlld:pubmed
pubmed-article:3349143pubmed:authorpubmed-author:GordienkoS...lld:pubmed
pubmed-article:3349143pubmed:issnTypePrintlld:pubmed
pubmed-article:3349143pubmed:volume105lld:pubmed
pubmed-article:3349143pubmed:ownerNLMlld:pubmed
pubmed-article:3349143pubmed:authorsCompleteYlld:pubmed
pubmed-article:3349143pubmed:pagination163-5lld:pubmed
pubmed-article:3349143pubmed:dateRevised2008-10-8lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:meshHeadingpubmed-meshheading:3349143-...lld:pubmed
pubmed-article:3349143pubmed:year1988lld:pubmed
pubmed-article:3349143pubmed:articleTitle[Homeostatic role of calcitonin antibodies in calcium metabolism in experimental diabetes mellitus].lld:pubmed
pubmed-article:3349143pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3349143pubmed:publicationTypeEnglish Abstractlld:pubmed